Want to join the conversation?
$ZUMZ posted a net loss in 2Q16, hurt by an operating loss of $1.14MM compared to a $5.3MM operating profit in 2Q15. Net loss was $0.8MM or $0.03 per diluted share, compared to net income of $3.2MM or $0.11 per diluted share last year. Net sales decreased 0.9% to $178.3MM from $179.8MM in 2Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?